• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过表达的睡眠美人转座酶可使小鼠和犬血友病 B 模型中持续的表型纠正。

Hyperactive sleeping beauty transposase enables persistent phenotypic correction in mice and a canine model for hemophilia B.

机构信息

Max von Pettenkofer-Institut, Department of Virology, Ludwig-Maximilians-Universität Munich, Munich, Germany.

出版信息

Mol Ther. 2010 Nov;18(11):1896-906. doi: 10.1038/mt.2010.169. Epub 2010 Aug 17.

DOI:10.1038/mt.2010.169
PMID:20717103
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2990515/
Abstract

Sleeping Beauty (SB) transposase enables somatic integration of exogenous DNA in mammalian cells, but potency as a gene transfer vector especially in large mammals has been lacking. Herein, we show that hyperactive transposase system delivered by high-capacity adenoviral vectors (HC-AdVs) can result in somatic integration of a canine factor IX (cFIX) expression-cassette in canine liver, facilitating stabilized transgene expression and persistent haemostatic correction of canine hemophilia B with negligible toxicity. We observed stabilized cFIX expression levels during rapid cell cycling in mice and phenotypic correction of the bleeding diathesis in hemophilia B dogs for up to 960 days. In contrast, systemic administration of an inactive transposase system resulted in rapid loss of transgene expression and transient phenotypic correction. Notably, in dogs a higher viral dose of the active SB transposase system resulted into transient phenotypic correction accompanied by transient increase of liver enzymes. Molecular analysis of liver samples revealed SB-mediated integration and provide evidence that transgene expression was derived mainly from integrated vector forms. Demonstrating that a viral vector system can deliver clinically relevant levels of a therapeutic protein in a large animal model of human disease paves a new path toward the possible cure of genetic diseases.

摘要

睡美人(SB)转座酶能够使外源性 DNA 在哺乳动物细胞中进行体整合,但作为基因转移载体,特别是在大型哺乳动物中的效力一直不足。在此,我们展示了通过高容量腺病毒载体(HC-AdV)传递的 hyperactive 转座酶系统可导致犬因子 IX(cFIX)表达盒在犬肝脏中进行体整合,从而促进稳定的转基因表达和对犬血友病 B 的持续止血纠正,且毒性可忽略不计。我们观察到在快速细胞周期中,在小鼠中观察到稳定的 cFIX 表达水平,并且在血友病 B 犬中观察到出血倾向的表型纠正长达 960 天。相比之下,全身性给予无活性转座酶系统会导致转基因表达迅速丧失和表型纠正短暂。值得注意的是,在犬中,高剂量的活性 SB 转座酶系统会导致短暂的表型纠正,同时伴随着肝酶的短暂升高。对肝组织样本的分子分析揭示了 SB 介导的整合,并提供了证据表明转基因表达主要来源于整合的载体形式。证明病毒载体系统可以在人类疾病的大型动物模型中递送具有临床相关性的治疗蛋白水平,为治疗遗传疾病开辟了新的途径。

相似文献

1
Hyperactive sleeping beauty transposase enables persistent phenotypic correction in mice and a canine model for hemophilia B.过表达的睡眠美人转座酶可使小鼠和犬血友病 B 模型中持续的表型纠正。
Mol Ther. 2010 Nov;18(11):1896-906. doi: 10.1038/mt.2010.169. Epub 2010 Aug 17.
2
Development of adenovirus hybrid vectors for Sleeping Beauty transposition in large mammals.用于大型哺乳动物中睡美人转座的腺病毒杂交载体的开发。
Curr Gene Ther. 2011 Oct;11(5):363-74. doi: 10.2174/156652311797415890.
3
Integration profile and safety of an adenovirus hybrid-vector utilizing hyperactive sleeping beauty transposase for somatic integration.利用超活睡美人转座酶进行体细胞整合的腺病毒杂交载体的整合谱和安全性。
PLoS One. 2013 Oct 4;8(10):e75344. doi: 10.1371/journal.pone.0075344. eCollection 2013.
4
Helper-Independent Sleeping Beauty transposon-transposase vectors for efficient nonviral gene delivery and persistent gene expression in vivo.用于高效非病毒基因递送和体内持续基因表达的辅助独立型睡美人转座子-转座酶载体。
Mol Ther. 2003 Oct;8(4):654-65. doi: 10.1016/s1525-0016(03)00216-8.
5
Prolonged Expression of Secreted Enzymes in Dogs After Liver-Directed Delivery of Sleeping Beauty Transposons: Implications for Non-Viral Gene Therapy of Systemic Disease.肝脏定向递送睡美人转座子后犬体内分泌酶的长期表达:对全身性疾病非病毒基因治疗的启示
Hum Gene Ther. 2017 Jul;28(7):551-564. doi: 10.1089/hum.2017.004. Epub 2017 May 19.
6
A gene-deleted adenoviral vector results in phenotypic correction of canine hemophilia B without liver toxicity or thrombocytopenia.一种基因缺失的腺病毒载体可实现犬类血友病B的表型纠正,且无肝毒性或血小板减少症。
Blood. 2003 Oct 1;102(7):2403-11. doi: 10.1182/blood-2003-01-0314. Epub 2003 Jun 12.
7
In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs.体内肝脏基因治疗:血友病B犬中因子IX缺乏症的完全纠正,尽管是短暂的。
Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2353-7. doi: 10.1073/pnas.91.6.2353.
8
Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system.使用DNA转座子系统在正常和血友病小鼠中的体细胞整合及长期转基因表达
Nat Genet. 2000 May;25(1):35-41. doi: 10.1038/75568.
9
Sustained phenotypic correction of hemophilia B dogs with a factor IX null mutation by liver-directed gene therapy.通过肝脏定向基因疗法对患有因子IX无效突变的血友病B犬进行持续的表型校正。
Blood. 2002 Apr 15;99(8):2670-6. doi: 10.1182/blood.v99.8.2670.
10
Hyperactive piggyBac transposons for sustained and robust liver-targeted gene therapy.用于持续且强效肝脏靶向基因治疗的高活性piggyBac转座子
Mol Ther. 2014 Sep;22(9):1614-24. doi: 10.1038/mt.2014.131. Epub 2014 Jul 18.

引用本文的文献

1
Episomes and Transposases-Utilities to Maintain Transgene Expression from Nonviral Vectors.附加体和转座酶——维持非病毒载体中转基因表达的工具。
Genes (Basel). 2022 Oct 16;13(10):1872. doi: 10.3390/genes13101872.
2
The use of adenoviral vectors in gene therapy and vaccine approaches.腺病毒载体在基因治疗和疫苗方法中的应用。
Genet Mol Biol. 2022 Oct 7;45(3 Suppl 1):e20220079. doi: 10.1590/1678-4685-GMB-2022-0079. eCollection 2022.
3
Safe and efficient hematopoietic stem cell transduction in nonhuman primates using HDAd5/35++ vectors.使用HDAd5/35++载体在非人灵长类动物中进行安全有效的造血干细胞转导。
Mol Ther Methods Clin Dev. 2021 Dec 6;24:127-141. doi: 10.1016/j.omtm.2021.12.003. eCollection 2022 Mar 10.
4
Novel vectors and approaches for gene therapy in liver diseases.用于肝病基因治疗的新型载体和方法。
JHEP Rep. 2021 Apr 30;3(4):100300. doi: 10.1016/j.jhepr.2021.100300. eCollection 2021 Aug.
5
Curative in vivo hematopoietic stem cell gene therapy of murine thalassemia using large regulatory elements.利用大调控元件对小鼠地中海贫血进行体内造血干细胞基因治疗的疗效。
JCI Insight. 2020 Aug 20;5(16):139538. doi: 10.1172/jci.insight.139538.
6
The Evolution of Gene Therapy in the Treatment of Metabolic Liver Diseases.基因治疗在代谢性肝病治疗中的发展。
Genes (Basel). 2020 Aug 10;11(8):915. doi: 10.3390/genes11080915.
7
The FDA-Approved Drug Nelfinavir Inhibits Lytic Cell-Free but Not Cell-Associated Nonlytic Transmission of Human Adenovirus.美国食品和药物管理局批准的药物奈非那韦抑制游离细胞但不抑制非裂解细胞相关的人腺病毒非裂解性传播。
Antimicrob Agents Chemother. 2020 Aug 20;64(9). doi: 10.1128/AAC.01002-20.
8
Adenovirus vectors in hematopoietic stem cell genome editing.腺相关病毒载体在造血干细胞基因组编辑中的应用。
FEBS Lett. 2019 Dec;593(24):3623-3648. doi: 10.1002/1873-3468.13668. Epub 2019 Nov 20.
9
Enhanced Tropism of Species B1 Adenoviral-Based Vectors for Primary Human Airway Epithelial Cells.基于B1型腺病毒的载体对原代人呼吸道上皮细胞的嗜性增强
Mol Ther Methods Clin Dev. 2019 Jul 12;14:228-236. doi: 10.1016/j.omtm.2019.07.001. eCollection 2019 Sep 13.
10
Gene Therapy Leaves a Vicious Cycle.基因治疗导致恶性循环。
Front Oncol. 2019 Apr 24;9:297. doi: 10.3389/fonc.2019.00297. eCollection 2019.

本文引用的文献

1
Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates.新型超活性 Sleeping Beauty 转座酶的分子进化使脊椎动物中强大稳定的基因转移成为可能。
Nat Genet. 2009 Jun;41(6):753-61. doi: 10.1038/ng.343. Epub 2009 May 3.
2
A rapid protocol for construction and production of high-capacity adenoviral vectors.一种用于构建和生产高容量腺病毒载体的快速方案。
Nat Protoc. 2009;4(4):547-64. doi: 10.1038/nprot.2009.4.
3
Persistence of high-capacity adenoviral vectors as replication-defective monomeric genomes in vitro and in murine liver.高容量腺病毒载体作为复制缺陷型单体基因组在体外和小鼠肝脏中的持久性。
Hum Gene Ther. 2009 Aug;20(8):883-96. doi: 10.1089/hum.2009.020.
4
Bioengineered factor IX molecules with increased catalytic activity improve the therapeutic index of gene therapy vectors for hemophilia B.具有更高催化活性的生物工程化因子 IX 分子可提高血友病 B 基因治疗载体的治疗指数。
Hum Gene Ther. 2009 May;20(5):479-85. doi: 10.1089/hum.2008.084.
5
Efficient, long-term hepatic gene transfer using clinically relevant HDAd doses by balloon occlusion catheter delivery in nonhuman primates.在非人类灵长类动物中,通过球囊闭塞导管递送使用临床相关的高剂量腺相关病毒载体进行高效、长期的肝脏基因转移。
Mol Ther. 2009 Feb;17(2):327-33. doi: 10.1038/mt.2008.257. Epub 2008 Dec 2.
6
Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy.采用肝脏靶向性腺相关病毒2介导的因子IX基因疗法对易产生抑制剂的血友病B犬进行长期校正。
Blood. 2009 Jan 22;113(4):797-806. doi: 10.1182/blood-2008-10-181479. Epub 2008 Oct 28.
7
Homologous and heterologous recombination between adenovirus vector DNA and chromosomal DNA.腺病毒载体DNA与染色体DNA之间的同源和异源重组。
J Gene Med. 2008 Nov;10(11):1176-89. doi: 10.1002/jgm.1246.
8
Emerging adenoviral vectors for stable correction of genetic disorders.用于稳定纠正遗传疾病的新型腺病毒载体。
Curr Gene Ther. 2007 Aug;7(4):272-83. doi: 10.2174/156652307781369074.
9
A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice.一种微小RNA调控的慢病毒载体介导血友病B小鼠的稳定校正。
Blood. 2007 Dec 15;110(13):4144-52. doi: 10.1182/blood-2007-03-078493. Epub 2007 Aug 28.
10
Site-directed transposon integration in human cells.人细胞中的位点特异性转座子整合
Nucleic Acids Res. 2007;35(7):e50. doi: 10.1093/nar/gkm089. Epub 2007 Mar 7.